Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Jim Cramer - Mad Money
ChemoCentryxCCXIDON'T BUYAug 15, 2022
A biotech with shares that more than doubled on a single day on a takeover bid by Biogen. At best, you'll make over a dollar per share if the deal goes ahead. If not, you will lose a fortune. Avoid.
$50.82
Stock price when the opinion was issued
$10.22
As of Jun 12, 2026. Market Open.
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
